Identifying biomarkers associated with venous infarction in acute/subacute cerebral venous thrombosis

20Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Among cerebral venous thrombosis (CVT) patients, those with venous infarction have more severe clinical presentations and worse outcomes. Identifying biomarkers associated with venous infarction in CVT may help understand the pathogenesis and provide potentially useful therapeutic markers. Fifty-two CVT patients were prospectively recruited and divided into three groups: acute/subacute CVT with venous infarction (ASVI, n=30), without venous infarction (ASOVI, n=13), and chronic CVT (n=9). Blood brain barrier (BBB) permeability-related proteins, including claudin-5, occludin, matrix metalloproteinase-9, glial fibrillary acidic protein, and S100B, and inflammation-related factor high-sensitivity C-reactive protein (hs-CRP), were tested in serum and/or cerebrospinal fluid upon admission. We compared these biomarkers between the three groups and investigated their associations with venous infarction and clinical symptom severity in acute/subacute CVT patients on admission using the NIH Stroke Scale (NIHSS). Serum hs-CRP was significantly higher in acute/subacute CVT patients than chronic CVT patients. For acute/subacute CVT patients, levels were significantly higher in the ASVI group than the ASOVI group for serum claudin-5 (medians 2.80 vs. 2.50 mg/I, respectively, P = 0.039) and hs-CRP (medians 17.25 vs. 2.27 mg/l, respectively, P = 0.003). Both these biomarkers, analyzed as categorical or continuous variables, were also significantly associated with venous infarction in acute/subacute CVT patients after logistic regression analysis. Additionally, hs-CRP was positively correlated with the NIHSS (r = 0.710, P < 0.001) on admission in acute/subacute CVT patients. In CVT patients, venous infarction was associated with BBB disruption and potentially inflammation. Hs-CRP might serve as a biomarker reflecting the clinical severity of CVT in the acute/subacute stages.

References Powered by Scopus

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis

1994Citations
N/AReaders
Get full text

Inflammation in Atherosclerosis. From Pathophysiology to Practice

1775Citations
N/AReaders
Get full text

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

1544Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Activating cGAS–STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis

105Citations
N/AReaders
Get full text

C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians

35Citations
N/AReaders
Get full text

Inflammation in Cerebral Venous Thrombosis

27Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Duan, J., Leng, X., Han, Z., Cai, Y., Wang, C., Rajah, G., … Ji, X. (2021). Identifying biomarkers associated with venous infarction in acute/subacute cerebral venous thrombosis. Aging and Disease, 12(1), 93–101. https://doi.org/10.14336/AD.2020.0405

Readers over time

‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Researcher 2

22%

Lecturer / Post doc 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

67%

Neuroscience 2

22%

Nursing and Health Professions 1

11%

Save time finding and organizing research with Mendeley

Sign up for free
0